Earnings call ANGLE reported a challenging H1 2025 with pharma revenue down and product revenue flat due to market delays, but achieved major strategic milestones including three completed large ...
Read ANGLE PLC ORD 10P (AGL.L) H1 FY2025 earnings call transcript on Yahoo Finance to keep your investing strategy up to date with all of the latest information ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback